000 01380 a2200385 4500
005 20250513152234.0
264 0 _c19981008
008 199810s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s002800050815
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStinson, S F
245 0 0 _aDetermination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1998
300 _a261-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xblood
650 0 4 _aChromatography, High Pressure Liquid
_xmethods
650 0 4 _aCyclin-Dependent Kinases
_xantagonists & inhibitors
650 0 4 _aDrug Stability
650 0 4 _aElectrochemistry
650 0 4 _aEnzyme Inhibitors
_xblood
650 0 4 _aFlavonoids
_xblood
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aLinear Models
650 0 4 _aPiperidines
_xblood
650 0 4 _aReproducibility of Results
700 1 _aHill, K
700 1 _aSiford, T J
700 1 _aPhillips, L R
700 1 _aDaw, T W
773 0 _tCancer chemotherapy and pharmacology
_gvol. 42
_gno. 4
_gp. 261-5
856 4 0 _uhttps://doi.org/10.1007/s002800050815
_zAvailable from publisher's website
999 _c9709784
_d9709784